Endologix Inc
ELGX
ELGX was delisted on the 15th of July, 2020.
63 hedge funds and large institutions have $54.4M invested in Endologix Inc in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 18 reducing their positions, and 20 closing their positions.
11% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 18
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
16% less funds holding
Funds holding: 75 → 63 (-12)
46% less capital invested
Capital invested by funds: $99.9M → $54.4M (-$45.5M)
60% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$2.22M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$1.48M |
| 4 |
Renaissance Technologies
New York
|
+$566K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$438K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$2.97M |
| 2 |
ACM
Archon Capital Management
Seattle,
Washington
|
-$1.56M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.1M |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$800K |
| 5 |
D.E. Shaw & Co
New York
|
-$579K |
ELGX Hedge Fund Activity: Q3 2019 in Review
63 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Endologix Inc (ELGX) for Q3 2019, worth a combined $54.4M — down 46% from $99.9M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of ELGX and 8 opened new positions — a net loss of 12 holders — while 18 trimmed existing stakes and 20 added.
The largest buyer was First Light Asset Management, adding an estimated $2.22M. The largest seller was Morgan Stanley, cutting an estimated $2.97M.
- 63 institutional investors held Endologix Inc (ELGX) as of Q3 2019, down from 75 in Q2 2019.
- Funds reported $54.4M of Endologix Inc stock for Q3 2019, down 46% quarter-over-quarter.
- 8 funds opened new Endologix Inc positions in Q3 2019 and 20 closed out, a net change of -12 holders.
- The largest Endologix Inc buyer in Q3 2019 was First Light Asset Management, an estimated $2.22M added.
- The largest Endologix Inc seller in Q3 2019 was Morgan Stanley, an estimated $2.97M sold.
Based on aggregated 13F filings for Q3 2019.